Inactive Instrument

Highlights Lannett Company, Inc.

Equities

LCI

US5160122009

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Lannett Company, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-15	CI
Global markets live: Ford, AMD, Starbucks, Estee Lauder, CVS Health....	23-05-03
Lannett Company, Inc. Announces Positive Results from Pivotal Clinical Insulin Trial	23-04-04	CI
Reverse Split: 1 of 4	23-02-06	FA
Reverse Split: 1 of 4	23-02-06	FA
Earnings Flash (LCI) LANNETT COMPANY Reports Q2 Revenue $80.9M	23-02-01	MT
Earnings Flash (LCI) LANNETT COMPANY Posts Q2 Loss $-0.34	23-02-01	MT
Lannett Company, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-02-01	CI
Lannett Company, Inc. Raises Earnings Guidance for the Fiscal Year 2023	23-02-01	CI
Lannett to Implement 1-for-4 Reverse Stock Split	23-01-26	MT
Lannett Company Provides Development Update on Biosimilar Insulin Products	23-01-04	CI
Elite Pharmaceuticals Inc. and Lannett Company, Inc. Jointly Terminated the License, Supply and Distribution Agreement for Vigabatrin	22-11-10	CI
Earnings Flash (LCI) LANNETT COMPANY Posts Q1 Loss $-0.42	22-11-02	MT
Earnings Flash (LCI) LANNETT COMPANY Reports Q1 Revenue $75.1M	22-11-02	MT
Lannett Company, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022	22-11-02	CI
Lannett Company, Inc. Reiterates Earnings Guidance for the Fiscal Year 2023	22-11-02	CI
ETF Preview: ETFs, Futures Fall Premarket Friday	22-10-21	MT
Lannett Company, Inc. Receives FDA Approval to Manufacture Numbrino® at Seymour Plant	22-10-21	CI
Lannett Sells Several Discontinued New Drug Applications to Unnamed Company for $3 Million	22-10-19	MT
Lannett Company, Inc. Announces Subject Dosing Complete for Pivotal Clinical Trial of Biosimilar Insulin Glargine	22-08-31	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Lannett Company, Inc.

Equities

LCI

US5160122009

Highlights

Filters